InnoSkel's goal is to make a meaningful difference to the quality of life of patients affected by severe rare bone disorders. We work to accomplish this goal through patient centricity, scientific innovation and operational excellence.

Innoskel is using its proprietary technology platform to develop an effective and innovative gene therapy for a group of diseases called type II collagen disorders. We are also expanding the use of our technology and know-how to target and treat other rare bone conditions.